Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease
This is a pilot study to evaluate the safety and efficacy of unilateral gamma knife subthalamotomy for Parkinson's disease in patients deemed poor candidates for deep brain stimulation.
• Otherwise appropriate DBS candidates but deemed suboptimal for DBS on account of one or more of the following:
• advanced age greater than 74 years of age
• medical comorbidities
• need for continual anticoagulation
• poor candidates for general anesthesia based on cardiac, hepatic ,renal or pulmonary status
• high infection risk if internal DBS device hardware is placed (ie. Poor diabetes mellitus control)
• patient aversion to DBS
• Patients with asymmetric disease symptoms including:
• rigidity
• tremor
• bradykinesia
• dyskinesia
• More than 30% improvement in UPDRS score in ON versus OFF medication state, except:
• in the presence of disabling contralateral dyskinesias/dystonia limiting dose tolerance
• tremors that are medically refractory
• Patients who are on a stable medication regimen and demonstrating stable disease symptoms (absence of significant improvement or deterioration) for at least 3 months at the time of GKS, as determined by review of medical record
• MMSE score greater than or equal to 26